secwatch.observer — SEC 8-K summary
======================================

Issuer:     ABEONA THERAPEUTICS INC. (ABEO)
CIK:        0000318306
Form:       8-K
Filed at:   2026-03-20T23:59:59+00:00
Accession:  0001493152-26-011863
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Abeona Therapeutics adopts amended bylaws raising quorum to 50% and enhancing shareholder proposal rules
--------------------------------------------------------------------------------

- Stockholder meeting quorum increased from one-third to 50% of shares entitled to vote.
- Meetings may be held virtually by remote communication; stockholder list examination requirement eliminated.
- Enhanced disclosure and representation requirements for stockholder proposals and director nominations.
- Clarified procedures for calling, postponing, rescheduling annual and special meetings.
- Added procedural requirements for universal proxy rules compliance under Rule 14a-19.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/318306/000149315226011863/0001493152-26-011863-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/318306/000149315226011863/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-011863

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer